Mechanisms and disease consequences of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …
NAFLD and cardiovascular diseases: a clinical review
P Kasper, A Martin, S Lang, F Kuetting… - Clinical research in …, 2021 - Springer
Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in
Western countries and affects approximately 25% of the adult population. Since NAFLD is …
Western countries and affects approximately 25% of the adult population. Since NAFLD is …
[HTML][HTML] A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH
SM Francque, P Bedossa, V Ratziu… - … England Journal of …, 2021 - Mass Medical Soc
Background Management of nonalcoholic steatohepatitis (NASH) is an unmet clinical need.
Lanifibranor is a pan-PPAR (peroxisome proliferator–activated receptor) agonist that …
Lanifibranor is a pan-PPAR (peroxisome proliferator–activated receptor) agonist that …
[HTML][HTML] Non-alcoholic fatty liver disease: A patient guideline
SM Francque, G Marchesini, A Kautz, M Walmsley… - JHEP reports, 2021 - Elsevier
This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
Impact of non-invasive biomarkers on hepatology practice: past, present and future
Over the last two decades, there have been tremendous advances in the non-invasive
diagnosis and risk stratification of chronic liver diseases (CLDs). Non-invasive approaches …
diagnosis and risk stratification of chronic liver diseases (CLDs). Non-invasive approaches …
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health
problem, affecting up to a quarter of the world's adult population. The burden of NAFLD is …
problem, affecting up to a quarter of the world's adult population. The burden of NAFLD is …
The fecal mycobiome in non-alcoholic fatty liver disease
Background & Aims Studies investigating the gut-liver axis have largely focused on bacteria,
whereas little is known about commensal fungi. We characterized fecal fungi in patients with …
whereas little is known about commensal fungi. We characterized fecal fungi in patients with …
AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review
R Loomba, JK Lim, H Patton, HB El-Serag - Gastroenterology, 2020 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a leading etiology for chronic liver disease with
an immense public health impact and affects> 25% of the US and global population. Up to 1 …
an immense public health impact and affects> 25% of the US and global population. Up to 1 …
[HTML][HTML] Non-alcoholic fatty liver disease: Definition and subtypes
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …
Microbiota and fatty liver disease—the known, the unknown, and the future
S Lang, B Schnabl - Cell host & microbe, 2020 - cell.com
The liver communicates with the intestine via the portal vein, biliary system, and mediators in
the circulation. Microbes in the intestine maintain liver homeostasis but can also serve as a …
the circulation. Microbes in the intestine maintain liver homeostasis but can also serve as a …